Emine Kiliç

Dr. Emine Kiliç is a Researcher in the Department of Ophthalmology at Erasmus Medical Center in Rotterdam, the Netherlands. Her work focuses primarily on ocular oncology, with special emphasis on uveal melanoma and related metastatic conditions. She is actively involved in both clinical and translational research, contributing significantly to the understanding of genetic factors in eye cancer and publishing extensively in high-impact ophthalmology journals.

Research Interests

Dr. Kiliç's research spans several critical areas in ophthalmic oncology and molecular pathology. Her primary focus is on uveal melanoma, particularly examining the genetic and molecular characteristics that drive tumor progression and metastasis. She has made significant contributions to understanding the role of BAP1 mutations and SF3B1 mutations in uveal melanoma classification and prognosis. Her work also extends to circulating tumor DNA analysis as a potential biomarker for disease monitoring, and she explores innovative approaches using deep learning for molecular subclass prediction from standard histopathology slides.

Her research integrates clinical observation with advanced molecular techniques, bridging the gap between laboratory findings and patient care. Recent work demonstrates her commitment to developing more precise diagnostic tools and identifying potential therapeutic targets for metastatic uveal melanoma, with publications appearing consistently through 2024 and into 2025.

Publication Trends

Dr. Kiliç's recent publications reveal a strong focus on advancing diagnostic precision and understanding molecular mechanisms in uveal melanoma. Her work increasingly incorporates artificial intelligence approaches for histopathological analysis while maintaining a strong foundation in traditional molecular pathology techniques. There's a clear trajectory toward translational research that connects genetic findings with clinical outcomes, particularly in predicting metastatic potential and survival. Her collaborative work spans multiple institutions, reflecting the interdisciplinary nature of modern ocular oncology research.

Supervision and Collaborations

Dr. Kiliç has supervised 7 research projects according to available records, indicating her role in mentoring the next generation of ophthalmic researchers. Her extensive collaboration network includes researchers from various disciplines including molecular genetics, pathology, computational science, and clinical ophthalmology. The fingerprint analysis of her work shows strong connections to 12 similar research profiles, demonstrating her integration within the international ocular oncology research community.